Aminologics Co.,Ltd. (KOSDAQ:074430)

Aminologics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	23,078	26,456	18,882	11,999	12,738	8,861
Short-Term Investments	23,000	26,500	16,500	16,500	16,500	16,500
Trading Asset Securities	7,161	10,076	-	-	-	302.04
Cash & Short-Term Investments	53,239	63,032	35,382	28,499	29,238	25,663
Cash Growth	17.34%	78.14%	24.15%	-2.53%	13.93%	1.10%
Accounts Receivable	7,261	7,465	4,498	8,241	5,384	6,334
Other Receivables	464.14	249.38	151.8	175.94	260.15	155.36
Receivables	7,725	7,714	4,650	8,417	5,644	6,489
Inventory	5,172	4,440	6,083	7,977	8,335	6,373
Prepaid Expenses	378.64	150	213.72	189.9	285.58	83.86
Other Current Assets	3,525	3,274	188.02	166.43	66.39	69.7
Total Current Assets	70,040	78,610	46,517	45,249	43,569	38,679
Property, Plant & Equipment	2,412	2,612	3,090	2,630	2,826	2,120
Long-Term Investments	15,026	714.11	3,905	4,988	4,368	5,101
Other Intangible Assets	1,994	1,998	3,046	4,054	4,074	17,598
Long-Term Deferred Tax Assets	-	-	-	515.44	520.95	1,522
Other Long-Term Assets	244.52	244.02	231.23	231.48	224.05	221.75
Total Assets	89,716	84,178	56,789	57,668	55,582	65,243

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1,803	837.74	2,459	648.71	1,550	3,674
Accrued Expenses	359.77	320.1	288.89	247.74	207.15	159.36
Short-Term Debt	16,189	15,449	1,000	1,000	1,000	1,000
Current Portion of Leases	124.28	196.13	283.66	229.42	239.59	185.74
Other Current Liabilities	12,235	10,773	310.79	541.65	431.99	362.01
Total Current Liabilities	30,710	27,576	4,342	2,668	3,429	5,381
Long-Term Leases	531.74	569.02	734.77	589.53	749.49	468.03
Long-Term Unearned Revenue	41.19	39.53	17.12	-	-	-
Other Long-Term Liabilities	0	-0	-0	-	0	-
Total Liabilities	31,283	28,185	5,094	3,257	4,178	5,849

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	8,814	8,783	8,783	8,783	8,783	8,783
Additional Paid-In Capital	118,764	118,400	118,400	118,400	118,400	118,400
Retained Earnings	-67,715	-69,772	-73,997	-72,377	-74,814	-67,532
Comprehensive Income & Other	-1,430	-1,417	-1,490	-394.49	-965.24	-257.89
Shareholders' Equity	58,433	55,994	51,695	54,411	51,404	59,393
Total Liabilities & Equity	89,716	84,178	56,789	57,668	55,582	65,243

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	16,845	16,214	2,018	1,819	1,989	1,654
Net Cash (Debt)	36,395	46,817	33,364	26,680	27,249	24,010
Net Cash Growth	21.34%	40.32%	25.05%	-2.09%	13.49%	1.29%
Net Cash Per Share	414.39	533.07	370.70	303.78	310.26	273.38
Filing Date Shares Outstanding	88.14	87.83	87.83	87.83	87.83	87.83
Total Common Shares Outstanding	88.14	87.83	87.83	87.83	87.83	87.83
Working Capital	39,329	51,034	42,175	42,581	40,140	33,298
Book Value Per Share	662.96	637.54	588.61	619.53	585.29	676.25
Tangible Book Value	56,439	53,996	48,649	50,357	47,330	41,795
Tangible Book Value Per Share	640.33	614.80	553.92	573.36	538.90	475.88
Land	281.84	281.84	281.84	281.84	281.84	281.84
Buildings	840.38	840.38	840.38	840.38	840.38	840.38
Machinery	7,675	7,622	7,584	7,033	6,864	6,349

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 5, 2026

Data Sources Report a data error